These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21245444)

  • 41. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
    Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.
    Genzel GH; Stubbings W; Stîngu CS; Labischinski H; Schaumann R
    Int J Antimicrob Agents; 2014 Nov; 44(5):420-3. PubMed ID: 25264128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.
    Stubbings W; Leow P; Yong GC; Goh F; Körber-Irrgang B; Kresken M; Endermann R; Labischinski H
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4394-7. PubMed ID: 21709094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
    Shavit M; Pokrovskaya V; Belakhov V; Baasov T
    Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ciprofloxacin Functionalized Biogenic Gold Nanoflowers as Nanoantibiotics Against Pathogenic Bacterial Strains.
    Sreedharan SM; Singh R
    Int J Nanomedicine; 2019; 14():9905-9916. PubMed ID: 31908448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
    Ueda Y; Sunagawa M
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies.
    Cohen MA; Huband MD; Yoder SL; Gage JW; Roland GE
    J Antimicrob Chemother; 1998 Jun; 41(6):605-14. PubMed ID: 9687098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.
    Huovinen P; Wolfson JS; Hooper DC
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):255-7. PubMed ID: 1597204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
    Jones RN; Fritsche TR; Ge Y; Kaniga K; Sader HS
    J Antimicrob Chemother; 2005 Dec; 56(6):1047-52. PubMed ID: 16239290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth.
    Petersen PJ; Jones CH; Bradford PA
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):347-9. PubMed ID: 17662552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of three brands of Mueller-Hinton media for broth microdilution method to determine the susceptibility of multidrug-resistant Gram-negative bacilli against eravacycline.
    Hsu CK; Lai CC; Chen CC; Chen HJ; Tang HJ
    Int J Antimicrob Agents; 2024 May; 63(5):107117. PubMed ID: 38408495
    [No Abstract]   [Full Text] [Related]  

  • 57. Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates.
    Li ZX; Liu YN; Wang R; Li AM
    Clin Ter; 2015; 166(6):e374-80. PubMed ID: 26794819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phytochemical screening and antibacterial activity of Cyclamen persicum Mill tuber extracts.
    Alkowni R; Jodeh S; Hussein F; Jaradat N
    Pak J Pharm Sci; 2018 Jan; 31(1):187-192. PubMed ID: 29348102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro assessment of Ag2O nanoparticles toxicity against Gram-positive and Gram-negative bacteria.
    Negi H; Rathinavelu Saravanan P; Agarwal T; Ghulam Haider Zaidi M; Goel R
    J Gen Appl Microbiol; 2013; 59(1):83-8. PubMed ID: 23518522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent ciprofloxacin derivatives.
    Alsughayer A; Elassar AA; Hasan AA; Al Sagheer F
    Bioorg Chem; 2021 Mar; 108():104658. PubMed ID: 33517003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.